CG
DCPH

Cutler Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Cutler Group’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4K Sell
300
-200
-40% -$3.08K ﹤0.01% 1675
2023
Q4 		$8K Sell
500
-100
-17% -$1.28K ﹤0.01% 2546
2023
Q3 		$7K Hold
600
– – ﹤0.01% 2728
2023
Q2 		$8K Hold
600
– – ﹤0.01% 2412
2023
Q1 		$9K Sell
600
-200
-25% -$3.34K ﹤0.01% 2416
2022
Q4 		$13K Buy
800
+300
+60% +$4.88K ﹤0.01% 2552
2022
Q3 		$9K Sell
500
-1,300
-72% -$20.4K ﹤0.01% 3233
2022
Q2 		$23K Sell
1,800
-1,500
-45% -$16.6K ﹤0.01% 2574
2022
Q1 		$30K Sell
3,300
-1,100
-25% -$9.36K ﹤0.01% 2706
2021
Q4 		$42K Sell
4,400
-300
-6% -$5.64K ﹤0.01% 2542
2021
Q3 		$159K Sell
4,700
-3,050
-39% -$97.3K 0.01% 1551
2021
Q2 		$283K Buy
7,750
+2,451
+46% +$94.9K 0.01% 1091
2021
Q1 		$237K Buy
5,299
+3,600
+212% +$168K 0.01% 1164
2020
Q4 		$96K Sell
1,699
-1,100
-39% -$65.2K ﹤0.01% 1562
2020
Q3 		$143K Sell
2,799
-900
-24% -$44.1K 0.01% 1104
2020
Q2 		$220K Sell
3,699
-218
-6% -$11.7K 0.01% 829
2020
Q1 		$161K Sell
3,917
-27,744
-88% -$1.54M 0.01% 1082
2019
Q4 		$1.97M Buy
31,661
+31,461
+15,731% +$1.5M 0.12% 151
2019
Q3 		$6K Buy
+200
New +$5.92K ﹤0.01% 2959

Other funds holding DCPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Cutler Group's DCPH Position: Q1 2024 in Review

Cutler Group reduced its Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) stake by 40% in Q1 2024, selling an estimated $3.08K and leaving 300 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

Cutler Group first reported a position in DCPH in Q3 2019 and has held it in 19 quarters since. The position peaked at $1.97M in Q4 2019. 177 funds tracked by Wall St. Rank hold DCPH as of Q1 2024.

  • Cutler Group held 300 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $4K as of Q1 2024.
  • Cutler Group sold 200 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $3.08K.
  • Deciphera Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1675 holding.
  • Cutler Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2019 and has held it in 19 quarters since.
  • Cutler Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.97M in Q4 2019.
  • 177 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.